Jonathan Sporn
About Jonathan Sporn
Jonathan Sporn Founder and CEO
Jonathan Sporn is the Founder and CEO of a notable organization in the drug development industry. With over 25 years of experience in drug development spanning major companies such as Pfizer and Johnson & Johnson (JNJ), his leadership and expertise are well recognized in the pharmaceutical field. His experience in the industry underscores his capability in steering organizational success and innovation.
Jonathan Sporn Education and Expertise
Jonathan Sporn has a robust academic background in psychiatry and drug development. He served as an Assistant Professor of Psychiatry at Columbia University, contributing to the academic community through teaching and research. In addition to his teaching roles, Sporn has conducted significant academic research at prestigious institutions like Harvard University and the National Institutes of Health (NIH), further enhancing his expertise in the field.
Jonathan Sporn Background in Drug Development
Sporn's professional background is deeply rooted in drug development, with over 25 years of hands-on experience at Pfizer and Johnson & Johnson (JNJ). His extensive career in these leading pharmaceutical companies highlights his proficiency and dedication to advancing medical science and drug development. His work has significantly contributed to the development and innovation of pharmaceutical treatments.
Jonathan Sporn and Perception Neuroscience
Jonathan Sporn founded Perception Neuroscience, a company that focuses on innovative treatments for mental health disorders. Under his leadership, Perception Neuroscience achieved substantial milestones, leading to its acquisition by ATAI Life Sciences. This acquisition is a testament to the value and impact of the work conducted by the company under Sporn’s guidance.